Acquired in-process research and development expenses

Name: Pfizer Acquired in-process research and development expenses by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Pfizer·Business Segments·1 segment·Rolls up to Acquired IPR&D Expense

Breakdown

Segment	Q1 '26
Business Segments	$137.00M
Total	$137.00M

Segments

Business SegmentsView metric